Epidermal adenylate cyclase: stimulation of the histamine (H2) receptor by tolazoline.
Tolazoline (2-benzyl-2-imidazoline) activated adenylate cyclase in pig epidermal slices resulting in the accumulation of cyclic AMP. This effect was highly potentiated by the addition of the cyclic AMP-phosphodiesterase inhibitor, theophylline. Specific histamine (H2) receptor inhibitors (metiamide and cimetidine) completely blocked the tolazoline activation of adenylate cylase. At low concentrations (10-100 micrometer), a histamine (H1) receptor inhibitor (diphenhydramine) and a beta-adrenergic blocker (propranolol) did not inhibit this effect. The stimulation of cyclic AMP formation by the combination of tolazoline and histamine was about the same as the stimulation by histamine alone (nonadditive), whereas the stimulatory effects by tolazoline and epinephrine were additive. These data suggest that tolazoline, an alpha-adrenergic blocker, also activates adenylate cyclase at the histamine (H2) receptor site which is distinct from the beta-adrenergic receptor site. Another alpha-adrenergic blocker, phentolamine, did not have this effect.
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D004789:Enzyme Activation / Q000187:drug effects; D004817:Epidermis / Q000201:enzymology*; D011968:Receptors, Histamine / Q000187:drug effects*; D011970:Receptors, Histamine H2 / Q000187:drug effects*; D014043:Tolazoline / Q000494:pharmacology*
D011968:Receptors, Histamine; D011970:Receptors, Histamine H2; D014043:Tolazoline; D000242:Cyclic AMP; D000262:Adenylyl Cyclases